Illumina Stock News

Illumina said on Monday it had filed a registration statement with the U.S. securities regulator related to a potential divestiture of Grail , even as it challenges a European Union order to divest th

The NovaSeq X launch strengthens Illumina's (ILMN) competitive position in high-throughput sequencing.

Illumina, Inc. (NASDAQ:ILMN ) Piper Sandler 35th Annual Healthcare Conference November 29, 2023 11:30 AM ET Company Participants Jacob Thaysen - Chief Executive Officer Conference Call Participants Da

Illumina, Inc. (NASDAQ:ILMN ) Evercore ISI 6th Annual HealthCONx Conference November 28, 2023 10:50 AM ET Company Participants Joydeep Goswami - Chief Financial Officer Salli Schwartz - Vice President

Illumina (ILMN) introduces a new initiative to drive more equitable access to genomics globally.

As shares of Illumina Inc. ILMN, +5.46% trade near 10-year lows, analysts are reining in expectations for the DNA-sequencing company.

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Ligand Pharmaceuticals (LGND) or Illumina (ILMN). But which of these two stocks offers value

Illumina (ILMN) shares fell to their lowest level in a decade after the genetic research equipment manufacturer missed revenue estimates and slashed its guidance as customers pulled back on spending.

U.S. equities gained at midday after yesterday's selloff snapped long winning streaks for the S&P 500 and Nasdaq. Bond yields were lower after jumping yesterday when Fed Chair Jerome Powell suggested

Illumina Inc.'s stock ILMN, -13.91% fell 14% Friday to put it on track for its lowest close in 10 years, after the company after the maker of DNA-sequencing technology cut its full-year sales and prof

Illumina Inc (NASDAQ:ILMN) shares sank 11% in pre-market trading on Friday after the gene-testing company reduced its annual profit forecast for the second straight quarter, citing weakness in demand

Illumina (ILMN) reports solid earnings in the third quarter of 2023 amid a challenging macro environment.

Illumina, Inc. (NASDAQ:ILMN ) Q4 2023 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants Salli Schwartz - Vice President of Investor Relations Jacob Thaysen - Chief Executive Of

Although the revenue and EPS for Illumina (ILMN) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall St

U.S. genetic testing Illumina on Thursday trimmed its annual profit forecast for the second straight quarter, hurt by weakness in demand for its sequencing instruments, consumables and services.